Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish

References

• Basile DP, Anderson MD, Sutton TA. 2012. Pathophysiology of acute kidney injury. Compr Physiol. 2(2):1303–1353.
   PubMed Web of Science ®Google Scholar
• Chen B, Alam Z, Ge Y, Dworkin L, Gong R. 2022. Pharmacological melanocortin 5 receptor activation attenuates glomerular injury and proteinuria in rats with puromycin aminonucleoside nephrosis. Front Physiol. 13:887641.
   PubMed Web of Science ®Google Scholar
• Chevalier RL. 2016. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol. 311(1):F145–F161.
   PubMed Web of Science ®Google Scholar
• Choi Y, Seo H, Cho M, Kim J, Chung HS, Lee I, Kim MJ. 2021. Rutin inhibits DRP1-mediated mitochondrial fission and prevents ethanol-induced hepatotoxicity in HepG2 cells and zebrafish. Anim Cells Syst (Seoul). 25(1):74–81.
   PubMed Web of Science ®Google Scholar
• Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. 1980. Mechanism of cis-platinum nephrotoxicity: II. morphologic observations. J Pharmacol Exp Ther. 213(3):551–556.
   PubMed Web of Science ®Google Scholar
• Fu Y, Tang C, Cai J, Chen G, Zhang D, Dong Z. 2018. Rodent models of AKI-CKD transition. Am J Physiol Renal Physiol. 315(4):F1098–F1106.
   PubMed Web of Science ®Google Scholar
• Grond J, Weening JJ, van Goor H, Elema JD. 1988. Application of puromycin aminonucleoside and Adriamycin to induce chronic renal failure in the rat. Contrib Nephrol. 60:83–93.
   PubMedGoogle Scholar
• Guo X, Xu L, Velazquez H, Chen TM, Williams RM, Heller DA, Burtness B, Safirstein R, Desir GV. 2022. Kidney-targeted renalase agonist prevents cisplatin-induced chronic kidney disease by inhibiting regulated necrosis and inflammation. J Am Soc Nephrol. 33(2):342–356.
   PubMed Web of Science ®Google Scholar
• Hentschel DM, Mengel M, Boehme L, Liebsch F, Albertin C, Bonventre JV, Haller H, Schiffer M. 2007. Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol. 293(5):F1746–F1750.
   PubMed Web of Science ®Google Scholar
• Hentschel DM, Park KM, Cilenti L, Zervos AS, Drummond I, Bonventre JV. 2005. Acute renal failure in zebrafish: a novel system to study a complex disease. Am J Physiol Renal Physiol. 288(5):F923–F929.
   PubMed Web of Science ®Google Scholar
• Jerman S, Sun ZX. 2017. Using zebrafish to study kidney development and disease. Curr Top Dev Biol. 124:41–79. English.
   PubMed Web of Science ®Google Scholar
• Jung J, Kim J, Huh TL, Rhee M. 2021. Trim46 contributes to the midbrain development via Sonic Hedgehog signaling pathway in zebrafish embryos. Anim Cells Syst (Seoul). 25(1):56–64.
   PubMed Web of Science ®Google Scholar
• Kurzhagen JT, Dellepiane S, Cantaluppi V, Rabb H. 2020. AKI: an increasingly recognized risk factor for CKD development and progression. J Nephrol. 33(6):1171–1187.
   PubMed Web of Science ®Google Scholar
• McCampbell KK, Springer KN, Wingert RA. 2015. Atlas of cellular dynamics during zebrafish adult kidney regeneration. Stem Cells Int. 2015:547636.
   PubMed Web of Science ®Google Scholar
• Nguyen L, Wruck W, Erichsen L, Graffmann N, Adjaye J. 2022. The nephrotoxin puromycin aminonucleoside induces injury in kidney organoids differentiated from induced pluripotent stem cells. Cells. 11(4):635.
   PubMed Web of Science ®Google Scholar
• Petejova N, Martinek A, Zadrazil J, Teplan V. 2019. Acute toxic kidney injury. Ren Fail. 41(1):576–594.
   PubMed Web of Science ®Google Scholar
• Poureetezadi SJ, Wingert RA. 2016. Little fish, big catch: zebrafish as a model for kidney disease. Kidney Int. 89(6):1204–1210.
   PubMed Web of Science ®Google Scholar
• Rider SA, Bruton FA, Collins RG, Conway BR, Mullins JJ. 2018. The efficacy of puromycin and Adriamycin for induction of glomerular failure in larval zebrafish validated by an assay of glomerular permeability dynamics. Zebrafish. 15(3):234–242.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. 2020. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 16(5):269–288.
   PubMed Web of Science ®Google Scholar
• Ryan GB, Rodewald R, Karnovsky MJ. 1975. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis. Lab Invest. 33(5):461–468.
   PubMed Web of Science ®Google Scholar
• Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, Guttenplan J. 1986. Cisplatin nephrotoxicity. Am J Kidney Dis. 8(5):356–367.
   PubMed Web of Science ®Google Scholar
• Sato Y, Takahashi M, Yanagita M. 2020. Pathophysiology of AKI to CKD progression. Semin Nephrol. 40(2):206–215.
   PubMed Web of Science ®Google Scholar
• Thisse C, Thisse B. 2008. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 3(1):59–69.
   PubMed Web of Science ®Google Scholar
• Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. 2015. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 26(8):1765–1776.
   PubMed Web of Science ®Google Scholar
• Vera-Roman J, Krishnakantha TP, Cuppage FE. 1975. Gentamicin nephrotoxicity in rats. I. Acute biochemical and ultrastructural effects. Lab Invest. 33(4):412–417.
   PubMed Web of Science ®Google Scholar
• Wu H, Huang J. 2018. Drug-Induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies. Curr Drug Metab. 19(7):559–567.
   PubMed Web of Science ®Google Scholar
• Zhou W, Boucher RC, Bollig F, Englert C, Hildebrandt F. 2010. Characterization of mesonephric development and regeneration using transgenic zebrafish. Am J Physiol Renal Physiol. 299(5):F1040–F1047.
   PubMed Web of Science ®Google Scholar